Availability of data and material
Requests for data should be made to the corresponding author. Each request requires a research proposal including a clear research question and proposed analysis plan. Requests will be considered on an individual basis and are subject to review and approval by the ROCIT management committee and relevant human research ethics committees.
Code availability
Requests for code should be made to the corresponding author and will be considered on an individual basis by the study management committee.
References
Sudeep KC, Angurana SK (2021) Probiotic therapy in critical illness: does it hold water? Intensive Care Med. https://doi.org/10.1007/s00134-021-06428-9
Litton E, Anstey M, Broadhurst D, Chapman A, Currie A, Ferrier J, Gummer J, Higgins A, Lim J, Manning L, Myers E, Orr K, Palermo AM, Paparini A, Pellicano S, Raby E, Rammohan A, Regli A, Richter B, Salman S, Strunk T, Waterson S, Weight D, Wibrow B, Wood F (2021) Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT). Intensive Care Med 47:307–315
Agudelo-Ochoa GM, Valdes-Duque BE, Giraldo-Giraldo NA, Jaillier-Ramirez AM, Giraldo-Villa A, Acevedo-Castano I, Yepes-Molina MA, Barbosa-Barbosa J, Benitez-Paez A (2020) Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes 12:1707610
Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE (2016) Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care 20:262
Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, Huerta-Cepas J, Nieuwdorp M, Salojarvi J, Voigt AY, Zeller G, Sunagawa S, de Vos WM, Bork P (2016) Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352:586–589
Acknowledgements
The authors would like to thank the ROCIT participants and the consumers from the Consumer and Community Involvement Program (The University of Western Australia, MBDP M503, 35 Stirling Highway, Crawley, WA, 6009) for their contribution to the study design. The members of the ROCIT investigators are: Edward Litton PhD1,2,3, Matthew H Anstey MPH3,4, David Broadhurst PhD5, Andy Chapman MBBS6, Andrew Currie PhD7, Janet Ferrier BSc2, Joel Gummer PhD8, Alisa Higgins PhD9, Jolene Lim MPH1, Laurens Manning PhD10, Erina Myers BN4, Katrina Orr BPharm11, Anne-Marie Palermo RN1, Andrea Paparini PhD12, Susan Pellicano RN1, Edward Raby MBBS10, Anu Rammohan PhD13, Adrian Regli MD1,14, Bernhard Richter MD1,15, Sam Salman PhD3, Tobias Strunk PhD16, Sharon Waterson RN6, David Weight BSc1, Bradley Wibrow MSc4, and Fiona Wood MBBS17
Funding
ROCIT is funded by grants from the Department of Health, Government of Western Australia Research Translation Projects, the St John of God Hospital Foundation, and the Fiona Wood Foundation. Study drug was supplied by Metagenics Australia (previously Health World), 741 Nudgee Road, Northgate, Queensland 4013, Australia. The funding bodies and Metagenics Australia have had no input into the design, conduct, analysis or reporting of the trial. The study sponsor is the Fiona Stanley Fremantle Hospital Group, South Metropolitan Health Service, Western Australia.
Author information
Authors and Affiliations
Consortia
Contributions
EL, wrote the first draft of the letter, AC and ER contributed to critical revisions.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflicts of interest.
Ethics approval
The ROCIT protocol was prospectively approved by the human research ethics committee of all participating institutions and reported prior to completion of the study. This was the South Metropolitan Health Service Human Research Ethics Committee ref:RGS000004, and the St John of God Health Care Human Research Ethics Committee ref:1183.
Consent to participate
Consent to participate was provided prospectively from all participants or their legal surrogate.
Consent for publication
The signed consent forms for all participants included consent to publication of aggregate data. The authors all consent to publication of the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The members of “on behalf of the ROCIT Investigators” is present in the Acknowledgements section.
Rights and permissions
About this article
Cite this article
Litton, E., Currie, A., Raby, E. et al. Probiotics and sepsis: separating the signal from the noise. Intensive Care Med 47, 924–925 (2021). https://doi.org/10.1007/s00134-021-06427-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-021-06427-w